Comparative performances of flubendazole and albendazole in cystic echinococcosis: Ex vivo activity, plasma/cyst disposition, and efficacy in infected mice

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 12, 2011, Pages 5861-5867

  Ceballos, Laura ^a,c   Elissondo, Celina ^b,c   Bruni, Sergio Sánchez ^a,c   Denegri, Guillermo ^b,c   Lanusse, Carlos ^a,c   Alvarez, Luis ^a,c  

^a UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD NACIONAL DE MAR DEL PLATA   (Argentina)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ALBENDAZOLE SULFOXIDE; CYCLODEXTRIN; FLUBENDAZOLE; METHYLENE BLUE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTHELMINTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; ECHINOCOCCOSIS; ECHINOCOCCUS GRANULOSUS; EX VIVO STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INCUBATION TIME; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; PARASITE VIABILITY; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TIME TO MAXIMUM PLASMA CONCENTRATION;

ALBENDAZOLE; ANIMALS; ANTICESTODAL AGENTS; ECHINOCOCCOSIS; ECHINOCOCCUS GRANULOSUS; MEBENDAZOLE; MICE; MICE, INBRED BALB C; TREATMENT OUTCOME;

EID: 81555206666     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05105-11     Document Type: Article

References (36)

1. Alvarez, L., et al. 2009. Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs. Vet. Parasitol. 164:211-216.
2. Alvarez, L., L. Mottier, and C. Lanusse. 2007. Drug transfer into target helminth parasites. Trends Parasitol. 23:97-104. (Pubitemid 46274501)
3. Alvarez, L., S. Sánchez, and C. Lanusse. 1999. In vivo and ex vivo uptake of albendazole and its sulphoxide metabolite by cestode parasites: relationship with their kinetics behaviour in sheep. J. Vet. Pharmacol. Ther. 22:77-86. (Pubitemid 29245864)
4. Alvarez, L., C. Saumell, S. Sánchez, and C. Lanusse. 1996. Plasma disposition kinetics of albendazole metabolites in pigs fed different diets. Res. Vet. Sci. 60:152-156. (Pubitemid 26072231)
5. Casado, N., F. Rodríguez-Caabeiro, and S. Hernandez. 1986. In vitro survival of Echinococcus granulosus protoscoleces in several media, at 42°C and 37°C. Z. Parasitenkd. 72:273-278. (Pubitemid 16154390)
6. Ceballos, L., et al. 2006. Preliminary kinetic data on flubendazole formulated as a hydroxypropyl-β-cyclodextrin aqueous solution for use in sheep. J. Vet. Pharmacol. Ther. 29:85-86.
7. Ceballos, L., et al. 2008. Albendazole treatment in cystic echinococcosis: pharmacokinetic and clinical efficacy of two different aqueous formulations. Parasitol. Res. 103:355-362.
8. Ceballos, L., et al. 2009. Flubendazole in cystic echinococcosis therapy: pharmaco-parasitological evaluation in mice. Parasitol. Int. 58:354-358.
9. Davis, A., Z. S. H. Pawlowski, and H. Dixon. 1986. Multicenter trials of benzimidazole-carbamates in human echinococcosis. Bull. World Health Organ. 64:383-388. (Pubitemid 16020983)
10. Eckert, J., and P. Deplazes. 2004. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin. Microbiol. Rev. 17:107-135. (Pubitemid 38120932)
11. Elissondo, C., M. C. Dopchiz, M. Brasesco, and G. Denegri. 2004. Echinococcus granulosus: first report of microcysts formation from protoscoleces of cattle origin using the in vitro vesicular culture technique. Parasite 11:415-418. (Pubitemid 39656346)
12. Elissondo, M., et al. 2006. In vitro effects of flubendazole on Echinococcus granulosus protoscoleces. Parasitol. Res. 98:317-323. (Pubitemid 43289680)
13. Evrard, B., et al. 2002. Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-β- cyclodextrin. J. Control. Release 85:45-50. (Pubitemid 35449452)
14. Filice, C., and E. Brunetti. 1997. Use of PAIR in human cystic echinococcosis. Acta Trop. 64:95-107. (Pubitemid 27117822)
15. Gibaldi, M., and D. Perrier. 1982. Pharmacokinetics, 2nd ed., revised and expanded. Marcel Dekker, New York, NY.
16. Gyurik, R., et al. 1981. Metabolism of albendazole in cattle, sheep, rat, and mice. Drug Metab. Dispos. 9:503-508.
17. Kern, P. 2006. Medical treatment of echinococcosis under the guidance of Good Clinical Practice (GCP/ICH). Parasitol. Int. 55(suppl.):S273-S282. (Pubitemid 43188961)
18. Lacey, E. 1988. The role of the cytoskeletal protein tubulin in the mode of action and mechanism of drug resistance to benzimidazole. Int. J. Parasitol. 18:885-936. (Pubitemid 19001491)
19. Lacey, E. 1990. Mode of action of benzimidazoles. Parasitol. Today 6:112-115.
20. Lacey, E., R. Brady, R. K. Prichard, and T. Watson. 1987. Comparison of inhibition of polymerisation of mammalian tubulin and helminth ovicidal activity by benzimidazole carbamates. Vet. Parasitol. 23:105-119. (Pubitemid 17235558)
21. Lanusse, C., L. Gascon, and R. K. Prichard. 1995. Comparative plasma disposition kinetics of albendazole, fenbendazole, oxfendazole and their metabolites in adult sheep. J. Vet. Pharmacol. Ther. 18:196-203.
22. Lubega, G., and R. K. Prichard. 1991. Interaction of benzimidazole anthelmintics with Haemonchus contortus tubulin: binding affinity and anthelmintic efficacy. Exp. Parasitol. 73:203-209.
23. Marriner, S., and J. Bogan. 1980. Pharmacokinetic of albendazole in sheep. Am. J. Vet. Res. 41:1126-1129.
24. McKellar, Q. A., S. F. Sanchez Bruni, and D. G. Jones. 2004. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine. J. Vet. Pharmacol. Ther. 27:503-514. (Pubitemid 39665136)
25. Moreno, L., et al. 2004. Integrated pharmacological assessment of flubendazole potential for use in sheep: disposition kinetics, liver metabolism and parasite diffusion ability. J. Vet. Pharmacol. Ther. 27:299-308. (Pubitemid 39482235)
26. Mottier, L., et al. 2003. Transtegumental diffusion of benzimidazole anthelmintics into Moniezia benedeni: correlation with their octanol-water partition coefficients. Exp. Parasitol. 103:1-7.
27. Petersen, M., C. Friis, and H. Bjørn. 1997. A new in vitro assay of benzimidazole activity against adult Oesophagostomum dentatum. Int. J. Parasitol. 27:1333-1339. (Pubitemid 27502234)
28. Prichard, R. K., D. Hennessy, J. Steel, and E. Lacey. 1985. Metabolite concentrations in plasma following treatment of cattle with five anthelmintics. Res. Vet. Sci. 39:173-178. (Pubitemid 15237130)
29. Recco, P., et al. 1984. Hydatidose pleurale disseminee et hydatidoses hepatiques. Traitment post-operatoire par flubendazole a proposde 3 cas. Bull. Soc. Fr. Parasitol. 3:115-118.
30. Rogan, M., W. Hai, R. Richardson, E. Zeyhle, and P. Craig. 2006. Hydatid cysts: does every picture tell a story? Trends Parasitol. 22:431-438. (Pubitemid 44176412)
31. Sánchez, S., J. Sallovitz, E. Savio, Q. A. McKellar, and C. Lanusse. 2000. Comparative plasma bioavailability of two dosage forms of albendazole in dogs. Vet. J. 160:150-153.
32. Smego, R. A., and P. Sebanego. 2005. Treatment options for hepatic cystic echinococcosis. Int. J. Infect. Dis. 9:69-76. (Pubitemid 40253529)
33. Stamatakos, M., et al. 2009. Anthelmintic treatment: an adjuvant therapeutic strategy against Echinococcus granulosus. Parasitol. Int. 58:115-120.
34. Thompson, R. C. 1995. Biology and systematics of Echinococcus, p. 1-37. In R. C. Thompson and A. J. Lymbery (ed.), Echinococcus and hydatid disease. CAB International, London, United Kingdom.
35. Xiao, S. H., et al. 2002. Augmented bioavailability and cysticidal activity of albendazole reformulated in soybean emulsion in mice infected with Echinococcus granulosus or Echinococcus multilocularis. Acta Trop. 82: 77-84.
36. Xiao, S. H., et al. 1994. Effects of benzimidazole compounds on mice infected with secondary cysts of Echinococcus granulosus. Chin. Med. J. 107:521-532